Discount store B&M has confirmed the purchase of a selection of Wilko branches as the high street giant undergoes restructuring.
Monday marks the first day of job cuts at Wilko
Wilko is set to initiate the first wave of what could be numerous layoffs today, even as prospects for a partial business rescue continue.
Poundland and B&M are poised to acquire select Wilko stores, but the majority are at risk of shutting down.
The future looks bleak for most Wilko stores as thousands of jobs hang in the balance, given the administrators’ inability to secure a buyer for the beleaguered retailer.
Omega Diagnostics Gp (AIM:ODX) Directorate Change
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
Wilko enters administration, jeopardizing 12,000 positions.
Wilko, a prominent discount retailer on the high street, has entered administration, endangering 12,000 jobs due to the absence of a successful rescue deal.
British delivery giant Tuffnells crashes into administration
Tuffnells, one of the largest courier companies in the UK, has fallen into administration, jeopardising the jobs of nearly 2,300 employees and causing potential disruptions to the multitude of businesses
Omega Diagnostics Gp (AIM:ODX) Trading update
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, provides a trading update which reflects lower than expected revenue,
Omega Diagnostics Gp (AIM:ODX) US expansion update
Maiden US Laboratory FoodPrint® installation,
Omega Diagnostics Gp (AIM:ODX) Positive WHO data received for VISITECT® CD4 test
Test shows high diagnostic accuracy (specificity and sensitivity)
Omega Diagnostics Gp (AIM:ODX) Change of preliminary results date
Change of preliminary results date and investor presentation and update to CD4 sale
Omega Diagnostics Gp (AIM:ODX) Completion of Sale of the CD4 Business
Completion of Sale of the CD4 Business